Home
Scholarly Works
Elimination of 4-n-Butoxyphenylacethydroxamic Acid...
Journal article

Elimination of 4-n-Butoxyphenylacethydroxamic Acid (Bufexamac) in Man

Abstract

A GLC determination showed that about 80% of a dose of bufexamac (125–500 mg.) can be recovered from urine after acid hydrolysis as 4-n-butoxyphenylacetic acid. Excretion is apparently complete within 24 hr. Not more than 1% of the dose is excreted as free bufexamac or 4-butoxyphenylacetic acid. Enzymic hydrolysis indicated that about 75% of the dose is excreted with the hydroxamic function intact and that the elimination of bufexamac is mainly by conjugation, probably with glucuronic acid. About 6% of the dose was recovered from urine as 4-butoxyphenylacetic acid glucuronide. Bufexamac is fairly rapidly absorbed and eliminated, the peak rate of excretion of total 4-butoxyphenylacetic acid occurring 3–6 hr. after dosage. 4-Butoxyphenylacetic acid glucuronide is less rapidly excreted, and the ratio of bufexamac conjugate to 4-butoxyphenylacetic acid glucuronide decreases steadily with time after dosage. The rate of excretion of total 4-butoxy-phenylacetic acid could not be interpreted as log-linear during the period (16 hr.) of the kinetic studies.

Authors

Boreham DR; Cummings AJ; Dell D; Martin BK

Journal

Journal of Pharmaceutical Sciences, Vol. 61, No. 2, pp. 164–168

Publisher

Elsevier

Publication Date

February 1, 1972

DOI

10.1002/jps.2600610203

ISSN

1520-6017
View published work (Non-McMaster Users)

Contact the Experts team